FDA Investigator

Yvette M Lacour-Davis

Latest inspection on record: Louisville, United States, October 2023 · records back to 2008

Human DrugsMedical Devices & Rad HealthBiologicsAnimal Drugs & FeedsFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 147 inspections across 144 sites are on record.
  • 215 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2023-10-13.

At a glance

Inspections

147

Sites

144

Observations

215

Career since

Jan 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
James W. Sublett, M.D.13 Oct 2023Biologics
FOUNDATION CONSUMER HEALTHCARE, LLC14 Sep 2023Human Drugs
Firas B. Badin, M.D.4 Aug 2023Human DrugsView 483 →
Shane A. Foster, O.D.15 Jun 2023Human Drugs
Richard B. Powell, MD24 May 2023BiologicsView 483 →

Sites inspected

James W. Sublett, M.D.Louisville, United States1 insp.
FOUNDATION CONSUMER HEALTHCARE, LLCPittsburgh, United States1 insp.
Firas B. Badin, M.D.Lexington, United States1 insp.
Shane A. Foster, O.D.Athens, United States1 insp.
Richard B. Powell, MDBlue Ash, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Yvette M Lacour-Davis' 215 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site